Harkins Michael John 4
4 · GenMark Diagnostics, Inc. · Filed Oct 29, 2020
Insider Transaction Report
Form 4
Harkins Michael John
SVP, Sales
Transactions
- Sale
Common Stock
2020-10-27$11.34/sh−1,092$12,383→ 132,982 total
Footnotes (2)
- [F1]The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units.
- [F2]Includes 3,000 shares acquired under the GenMark Diagnostics, Inc. employee stock purchase plan, the reporting of which is exempt under both Rule 16b-3(d) and Rule 16b-3(c).